ArticleApplied biochemistry and biotechnology2026
Eupatorium perfoliatum Counteracts TNF-α Mediated Pathogenesis in Chikungunya Virus Infection.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Chikungunya virus (CHIKV) infection, a neglected tropical disease causes severe morbid symptoms that can be persistent and debilitating. CHIKV mediated pathogenesis is a complex combination of host and viral factors that results in immune responses causing incapacitating symptoms. A significant player of disease development is tumor necrosis factor-α (TNF-α), the villain responsible for unremitting inflammation and disease pathogenesis. This study explored the potential of TNF-α dysregulation that can enhance CHIKV mediated disease development along with the prospective of ultradiluted hydroethanolic preparation of Eupatorium perfoliatum to limit the symptoms. In silico molecular docking studies revealed that Eupatorium perfoliatum has strong molecular interactions with TNF-α. To substantiate the results, in vivo transcriptional and translational quantification of TNF-α by qRT-PCR and immunohistochemistry before and after treatment with candidate medicine was performed which produced similar outcome. Macroscopic and histology results also revealed neuropathogenesis and muscle waste caused by CHIKV infection and a systemic lowering of the same after treatment. Hub genes of TNF-α were analyzed to identify the other probable players that can augment CHIKV mediated pathogenesis. qRT-PCR results showed that the candidate medicine could lower the transcriptional overexpression of the hub genes thereby lowering disease pathogenesis. In vitro cytopathic effects upon infection were also lowered by the candidate medicine. Therefore, this study helps not only to recognize the possible villainous role of TNF-α but to also identify novel therapeutic markers of CHIKV mediated disease development by hub gene analysis and the potential of the alternative medicine, ultradiluted Eupatorium perfoliatum in lowering the same.
Indexed as
Identifiers
41420797What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.